TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
JD Health International, Inc. ( (HK:6618) ) has provided an update.
JD Health International, Inc. has announced its upcoming annual general meeting scheduled for June 20, 2025, in Beijing, China. Key agenda items include the adoption of the company’s financial statements for 2024, re-election of several directors, and re-appointment of Deloitte Touche Tohmatsu as auditors. The meeting will also consider granting the board authority to manage share allotments, reflecting the company’s strategic focus on maintaining robust governance and operational flexibility.
More about JD Health International, Inc.
JD Health International, Inc. operates in the healthcare industry, providing a range of health-related services and products. The company focuses on leveraging technology to offer online medical consultations, pharmaceutical retail, and health management services, primarily targeting the Chinese market.
YTD Price Performance: 27.94%
Average Trading Volume: 22,284,152
Technical Sentiment Signal: Sell
Current Market Cap: HK$115B
Find detailed analytics on 6618 stock on TipRanks’ Stock Analysis page.